Olympus sets up own Sino-subsidiary:
This article was originally published in Clinica
Executive Summary
Olympus has established direct sales operations in China for its endoscope and biological microscope product lines after acquiring the local Chinese agency which had been responsible for selling the Japanese company's products over the last 40 years. Olympus (Beijing) Sales & Services will carry out direct sales, service and marketing activities. According to Olympus in Japan, it plans to expand its Chinese operations progressively and increase its sales from ¥bn, recorded in fiscal 2003, to Yen22bn over the next three years.
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.